SecBot SecBot
144 ·Filed Apr 29, 2026

SNSE

Sensei Biotherapeutics, Inc.
BEARISH
Impact 5/10
Horizondays Processed6mo ago SEC0001959173-26-003128
Form 144 — notice of proposed sale of securities
Actionable Insight ▼ Bearish

Monitor for actual sale execution; if completed, it may signal insider concern over valuation or outlook. Combined with heavily bearish analyst consensus (0% bullish), the filing reinforces negative sentiment. Watch for further insider selling or company news.

DirectionBearish
Confidencemedium
Horizondays
Latest settled — T+20d
SNSE ▼ -41.17% at T+20d
SHORT call ✓ call won +41.17% · α vs SPY +46.63% · entry $28.30 → $16.65
Next anchor: T+60d due 3mo ago
Entry = T+0 close
Apr 29, 2026
via day close
T+1d
-5.94%
call +5.94% · α +6.96%
$26.62
settled 6mo ago
T+5d
-8.62%
call +8.62% · α +11.73%
$25.86
settled 6mo ago
T+20d
-41.17%
call +41.17% · α +46.63%
$16.65
settled 5mo ago
T+60d
Pending
due 3mo ago

Price Chart

Loading chart...

Executive Summary

Cambrian BioPharma Inc., a 10% stockholder of Sensei Biotherapeutics, filed a Form 144 on April 29, 2026, indicating intent to sell 155,142 shares of common stock, valued at approximately $4.96 million. This represents a significant portion of the company's $39 million market cap, potentially adding to bearish sentiment given the already unfavorable analyst consensus.

Key Facts

  • Cambrian BioPharma Inc. intends to sell 155,142 shares of SNSE common stock.
  • Estimated sale value is approximately $4,956,786.
  • Shares were acquired via private placement on January 10, 2020.
  • Filing date: April 29, 2026.

Financial Impact

Approximately $4.96 million, representing roughly 12.7% of current market cap ($39M).

stock supplyinsider selling pressure

Risk Factors

  • Insider selling pressure could weigh on stock price.
  • Potential further deterioration in fundamentals if sale signals loss of confidence.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-003128
Document: 0001959173-26-003128-index.html0001959173-26-003128
Document: 0001959173-26-003128.txt0001959173-26-003128
15 reports for SNSE
Performance horizon
100% Hit rate @ T+5 3 of 3 directional calls Went positive at some point 3 of 3 best @ T+20▲ +42.80%Apr 28, 2026
Filters
Rows
Reports for SNSE — sortable, filterable
TypeNow
Jun 16, 2026
19w ago
3
NEUTRAL ★ 3/10
$13.86awaiting T+5——
Jun 15, 2026
19w ago
8-K
BEARISH ★ 6/10
$13.04awaiting T+5——
Jun 15, 2026
19w ago
EFFECT
BEARISH ★ 6/10
$13.04awaiting T+5——
Jun 10, 2026
19w ago
S-3/A
NEUTRAL ★ 4/10
$10.79 $13.85▲ +28.36%▲ +27.93%—
Jun 10, 2026
19w ago
8-K
NEUTRAL ★ 3/10
$10.79 $13.85▲ +28.36%▲ +27.93%—
Jun 2, 2026
21w ago
10-K/A
NEUTRAL ★ 3/10
$16.10 $12.63▼ −21.53%▼ −18.56%—
Jun 2, 2026
21w ago
S-3/A
BEARISH ★ 6/10
$16.10 $12.63▲ +21.53%▲ +18.56%—
Jun 1, 2026
21w ago
Insider Cluster
BEARISH ★ 7/10
$16.10 $12.63▲ +21.53%▲ +18.56%—
May 22, 2026
22w ago
DEFA14A
NEUTRAL ★ 3/10
$16.47 $19.79▲ +20.16%▲ +19.07%—
May 22, 2026
22w ago
8-K
NEUTRAL ★ 2/10
$16.47 $19.79▲ +20.16%▲ +19.07%—
Showing 10 of 15

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 29, 2026